Published in J Clin Microbiol on April 01, 1998
Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System. J Clin Microbiol (2003) 1.73
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Review Article: Recent advancements in optofluidic flow cytometer. Biomicrofluidics (2010) 1.45
Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol (2003) 1.42
Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol (2002) 1.23
Stability of plasma human immunodeficiency virus load in VACUTAINER PPT plasma preparation tubes during overnight shipment. J Clin Microbiol (2000) 1.18
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1999) 1.07
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes. J Clin Microbiol (2009) 0.96
Universally applicable three-dimensional hydrodynamic microfluidic flow focusing. Lab Chip (2013) 0.94
Follow-up on diagnostic proficiency of laboratories equipped to perform orthopoxvirus detection and quantification by PCR: the second international external quality assurance study. J Clin Microbiol (2006) 0.86
Associations of common variants in the BST2 region with HIV-1 acquisition in African American and European American people who inject drugs. AIDS (2015) 0.85
Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0. Clin Diagn Lab Immunol (2001) 0.84
Comparison of blood collected in acid-citrate-dextrose and EDTA for use in human immunodeficiency virus peripheral blood mononuclear cell cultures. J Clin Microbiol (2000) 0.82
Expanding access to HIV viral load testing: a systematic review of RNA stability in EDTA tubes and PPT beyond current time and temperature thresholds. PLoS One (2014) 0.79
Efficient quantification of HIV-1 in heparin plasma spiked with cultured HIV-1 by the Roche Cobas TaqMan and Abbott RealTime HIV-1 tests. J Clin Microbiol (2012) 0.75
Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive). J Clin Microbiol (2002) 0.75
Investigation of effects of acid citrate dextrose and EDTA on ability to quantitatively culture human immunodeficiency virus. J Clin Microbiol (2000) 0.75
TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection. J Clin Microbiol (2005) 0.75
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90
Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol (1994) 6.76
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Interference of heparin with the polymerase chain reaction. Biotechniques (1990) 3.77
Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71
Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol (1991) 3.32
A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods (1994) 3.13
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis (1994) 2.60
Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J Clin Microbiol (1995) 1.98
Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J Clin Microbiol (1993) 1.94
Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci U S A (1995) 1.25
Quantitation of human immunodeficiency virus DNA by using the polymerase chain reaction. J Clin Microbiol (1990) 1.25
Survival of human immunodeficiency virus in suspension and dried onto surfaces. J Clin Microbiol (1994) 1.18
Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy. J Virol (1995) 1.16
Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep (1989) 1.13
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group. J Infect Dis (1996) 1.02
Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J Clin Microbiol (1992) 6.33
Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol (1993) 4.50
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1996) 4.44
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol (1999) 2.68
Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med (1992) 2.33
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA (1994) 2.14
Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol (1997) 2.11
A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis (1999) 2.07
Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med (1984) 2.05
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med (1994) 1.97
Differential transcription from the long terminal repeats of integrated avian leukosis virus DNA. J Virol (1986) 1.91
Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89
Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. Clin Nephrol (1999) 1.71
Efficient packaging of readthrough RNA in ALV: implications for oncogene transduction. Science (1987) 1.65
Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet (1991) 1.60
Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol (1999) 1.57
Endovascular ruptured abdominal aortic aneurysm repair (EVRAR): a systematic review. Eur J Vasc Endovasc Surg (2007) 1.56
Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis (1990) 1.54
The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis (1992) 1.45
Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol (1985) 1.40
Improved method for i.r. determination of the degree of N-acetylation of chitosan. Int J Biol Macromol (1992) 1.38
Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol (2001) 1.37
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis (1998) 1.37
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. Am J Obstet Gynecol (1993) 1.31
Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.30
Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures. Antimicrob Agents Chemother (1977) 1.27
In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside. Antimicrob Agents Chemother (1976) 1.24
Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis (1998) 1.23
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol (1993) 1.22
Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis (1993) 1.21
Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine. Antimicrob Agents Chemother (1982) 1.20
A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. Clin Nephrol (2007) 1.14
Infarction of the optic nerve head in children with accelerated hypertension. Br J Ophthalmol (1981) 1.13
A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis (1980) 1.13
The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. J Infect Dis (1984) 1.13
Gorham's disease: a case (including dental presentation) of vanishing bone disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.13
Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis (1994) 1.10
An assessment of microbiological water quality of six water source categories in north-east Uganda. J Water Health (2010) 1.09
Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J (2001) 1.09
Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis (1982) 1.09
T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol (1994) 1.05
Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol (1991) 1.05
Increased susceptibility of neonatal monocyte/macrophages to HIV-1 infection. AIDS Res Hum Retroviruses (1993) 1.04
Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med (1993) 1.02
Diagnosis of HIV infection in children. Pediatr Clin North Am (2000) 1.02
Cellular (T cell) immunity in the human newborn. Pediatrics (1979) 1.01
Microinjecting DNA into mouse ova to study DNA replication and gene expression and to produce transgenic animals. Biotechniques (1990) 1.01
Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol (2002) 0.99
The role of thymectomy in red cell aplasia. Ann Thorac Surg (1979) 0.98
Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol (1997) 0.97
High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children. J Pediatr (1979) 0.97
Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection. Arch Pathol Lab Med (1982) 0.96
Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J Pediatr (1987) 0.95
The role of bougienage in the management of achalasia--the need for reappraisal. Gastrointest Endosc (1982) 0.95
Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol (1985) 0.95
Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy. J Infect Dis (2000) 0.93
Peritoneal venous shunting for ascites: a 15-year perspective. Am Surg (1982) 0.93
Lymphokine production by human milk lymphocytes. Infect Immun (1981) 0.92
Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol (1998) 0.91
Prevention of mother-to-child transmission of HIV-1 infection. AIDS (1997) 0.90
Simple sensitive microbioassay for adenine arabinoside and hypoxanthine arabinoside in human plasma. Antimicrob Agents Chemother (1978) 0.90
Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon. J Infect Dis (1986) 0.89
Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis (1996) 0.88
Deficient lymphokine production of newborn lymphocytes. Pediatr Res (1983) 0.87
Comparison of Western Blot Analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies. J Med Virol (1985) 0.86
Experimental and clinical evaluation of heparin-impregnated cloth-covered cardiac valves used without systemic anticoagulation. Ann Thorac Surg (1974) 0.85
Comparison of monoclonal and polyclonal antibody for confirmation of cytomegalovirus isolates by fluorescent staining. J Clin Microbiol (1984) 0.85
A search for the optimal stimulus. Brain Cogn (1998) 0.84
IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccines. J Infect Dis (1977) 0.84
Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. J Infect Dis (1999) 0.83
Antibody response to herpes simplex virus glycoproteins gB and gD. J Med Virol (1990) 0.83
Treatment of first episode genital HSV with oral acyclovir: long term follow-up of recurrences. A preliminary report. Scand J Infect Dis Suppl (1985) 0.82
Timing of lymphocyte activation in neonates infected with human immunodeficiency virus. Clin Diagn Lab Immunol (1997) 0.82
In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children. Pediatr Res (1993) 0.81
A prospective study of the effects of acyclovir treatment on the HSV-2 lymphoproliferative response of persons with frequently recurring HSV-2 genital infections. J Infect Dis (1989) 0.80
Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis. Eur J Neurol (2013) 0.80
Giant cell carcinoma of the lung exhibiting a large, well-circumscribed photon deficiency in ventilation/perfusion scintigrams. Radiat Med (1992) 0.79
Longitudinal study of influenza B symptomatology and interferon production in children and college students. Pediatr Infect Dis (1983) 0.79
The use of acyclovir in children. Pediatr Infect Dis (1984) 0.79
Multicomponent gas chromatographic analysis of urinary steroids excreted by an infant with a defect in aldosterone biosynthesis. Acta Endocrinol (Copenh) (1976) 0.79
Subrenal capsule assay: feasibility of transporting tissues to a central facility for testing. Cancer Treat Rep (1985) 0.78
Pharmacokinetics of oral zidovudine administered during labour: a preliminary study. HIV Med (2007) 0.78
Staphylococcus aureus sensitivity to various antibiotics--a national survey in Ireland 1993. Ir J Med Sci (1996) 0.78